Socioeconomic and geographic variations in the prevalence, awareness, treatment and control of dyslipidemia in middle-aged and older Chinese

P Song, M Zha, X Yang, Y Xu, H Wang, Z Fang, X Yang… - Atherosclerosis, 2019 - Elsevier
Background and aims Unevenly socioeconomic development and nutrition transition might
bring large variations in the epidemiology of dyslipidemia. We aimed to estimate the …

[HTML][HTML] The prevalence, awareness, treatment, and control of dyslipidemia in northeast China: a population-based cross-sectional survey

FL Zhang, YQ Xing, YH Wu, HY Liu, Y Luo… - Lipids in health and …, 2017 - Springer
Background Dyslipidemia is an important independent modifiable risk factor for
cardiovascular disease. The aim of this study was to explore the current prevalence …

The prevalence, awareness, treatment and control of dyslipidemia among adults in China

L Pan, Z Yang, Y Wu, RX Yin, Y Liao, J Wang, B Gao… - Atherosclerosis, 2016 - Elsevier
Objectives To analyze the prevalence, awareness, treatment, control and epidemiological
characteristics of dyslipidemia in Chinese adults. Methods In this cross-sectional study, we …

Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: A cross-sectional study

L Xing, L Jing, Y Tian, H Yan, B Zhang, Q Sun… - Nutrition, Metabolism …, 2020 - Elsevier
Background and aims Management of dyslipidemia remains the cornerstone for prevention
of cardiovascular diseases. We aimed to evaluate the epidemiology of dyslipidemia in …

[HTML][HTML] Prevalence of dyslipidemia and associated risk factors among adults aged≥ 35 years in northern China: a cross-sectional study

Y Xi, L Niu, N Cao, H Bao, X Xu, H Zhu, T Yan… - BMC Public Health, 2020 - Springer
Background Cardiovascular disease (CVD) prevalence has increased continuously over the
last 30 years in China. Dyslipidemia is an important modifiable risk factor in CVD. We aimed …

Geographic variations in the prevalence, awareness, treatment, and control of dyslipidemia among Chinese adults in 2018–2019: a cross-sectional study

M Zhang, P Ke, X Zhang, YS Liu, XY Liu… - Biomedical and …, 2023 - Elsevier
Objective To investigate the spatial patterns of the prevalence, awareness, treatment, and
control rates of dyslipidemia at the provincial level in China. Methods A national and …

[HTML][HTML] Awareness, treatment, control, and determinants of dyslipidemia among adults in China

S Opoku, Y Gan, EA Yobo, D Tenkorang-Twum… - Scientific Reports, 2021 - nature.com
Effective management of dyslipidemia is important. This study aimed to determine the
awareness, treatment, control, and determinants of dyslipidemia in middle-aged and older …

Prevalence, awareness, treatment, and control of dyslipidemia among adults in Beijing, China

L Cai, L Zhang, A Liu, S Li, P Wang - Journal of atherosclerosis and …, 2012 - jstage.jst.go.jp
Aim: The present study aimed to determine the up-to-date prevalence, awareness,
treatment, and control of dyslipidemia, and their distribution and related influencing factors in …

Epidemiologic characteristics of dyslipidemia in people aged 18 years and over in China

WH Zhao, J Zhang, Y You, QQ Man, H Li… - … yu fang yi xue za zhi …, 2005 - europepmc.org
Objective To study the difference in prevalence of dyslipidemia, hypercholesterolemia,
hypertriglyceridemia and low blood high-density lipoprotein cholesterol (HDL-C) between …

[HTML][HTML] Prevalence, awareness, treatment and control of dyslipidemia among adults in northwestern China: the cardiovascular risk survey

J Luo, YT Ma, Z Yu, YN Yang, X Xie, X Ma, F Liu… - Lipids in health and …, 2014 - Springer
Aim The aim of this study was to estimate the prevalence, awareness, treatment, and control
of dyslipidemia in Xinjiang, China. Method Stratified sampling method was used to select a …